![]() | Up a level |
Seidel, Monika, de Meritens, Camille Rabesahala, Johnson, Louisa, Parthimos, Dimitris, Bannister, Mark, Thomas, N. Lowri, Ozekhome-Mike, Esizaze, Lai, F. Anthony and Zissimopoulos, Spyros
2020.
Identification of an amino-terminus determinant critical for ryanodine receptor/Ca2+ release channel function.
Cardiovascular Research
, cvaa043.
10.1093/cvr/cvaa043
![]() |
![]() |
Bannister, Mark, Thomas, Nia, Markus, Sikkel, Mukherjee, Saptarshi, Chloe, Maxwell, Kenneth, MacLeod and George, Christopher H. 2016. Questioning flecainide's mechanism of action in the treatment of catecholaminergic polymorphic ventricular tachycardia [Letter]. The Journal of Physiology 594 (21) , pp. 6431-6432. 10.1113/JP272497 |
|
George, Christopher, Mitchell, Alice N., Preece, Ryan, Bannister, Mark and Yousef, Zaheer 2016. Pleiotropic mechanisms of action of perhexiline in heart failure. Expert Opinion on Therapeutic Patents 26 (9) , pp. 1049-1059. 10.1080/13543776.2016.1211111 |
|
Bannister, Mark L., Alvarez-Laviada, Anita, Thomas, N. Lowri, Mason, Sammy A., Coleman, Sharon, du Plessis, Christo L., Moran, Abbygail T., Neill-Hall, David, Osman, Hasnah, Bagley, Mark C., MacLeod, Kenneth T., George, Christopher H. and Williams, Alan J.
2016.
Effect of flecainide derivatives on sarcoplasmic reticulum calcium release suggests a lack of direct action on the cardiac ryanodine receptor.
British Journal of Pharmacology
173
(15)
, pp. 2446-2459.
10.1111/bph.13521
![]() |
|
Bannister, Mark L., Thomas, N. Lowri, Sikkel, Markus B., Mukherjee, Saptarshi, Maxwell, Chloe, MacLeod, Kenneth T., George, Christopher H. and Williams, Alan J. 2015. The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2. Circulation Research 116 (8) , pp. 1324-1335. 10.1161/CIRCRESAHA.116.305347 |
![]() |
Mason, Sammy, Viero, Cedric, Euden, Joanne, Bannister, Mark, West, Duncan, Chen, S. R. Wayne and Williams, Alan John 2012. The contribution of hydrophobic residues in the pore-forming region of the ryanodine receptor channel to block by large tetraalkylammonium cations and Shaker B inactivation peptides. The Journal of General Physiology 140 (3) , pp. 325-339. 10.1085/jgp.201210851 |
|